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additional patients from five unrelated families using either 
targeted UBE3B sequencing in individuals with sugges-
tive facial dysmorphic features, or exome sequencing. Our 
results expand the clinical and mutational spectrum of the 
UBE3B-related disorder in several ways. First, we have 
identified UBE3B mutations in individuals who previously 
received distinct clinical diagnoses: two sibs with toriello–
Carey syndrome as well as the patient reported to have a 
“new” syndrome by Buntinx and Majewski in 1990. sec-
ond, we describe the adult phenotype and clinical variabil-
ity of the syndrome. third, we report on the first instance 
of homozygous missense alterations outside the HeCt 
domain of UBe3B, observed in a patient with mildly dys-
morphic facial features. We conclude that UBE3B muta-
tions cause a clinically recognizable and possibly under-
diagnosed syndrome characterized by distinct craniofacial 
Abstract Biallelic mutations of UBE3B have recently 
been shown to cause Kaufman oculocerebrofacial syn-
drome (also reported as blepharophimosis–ptosis–intellec-
tual disability syndrome), an autosomal recessive condition 
characterized by hypotonia, developmental delay, intellec-
tual disability, congenital anomalies, characteristic facial 
dysmorphic features, and low cholesterol levels. to date, 
six patients with either missense mutations affecting the 
UBe3B HeCt domain or truncating mutations have been 
described. Here, we report on the identification of homozy-
gous or compound heterozygous UBE3B mutations in six 
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features, hypotonia, failure to thrive, eye abnormalities, 
other congenital malformations, low cholesterol levels, and 
severe intellectual disability. We review the UBE3B-asso-
ciated phenotypes, including forms that can mimick tori-
ello–Carey syndrome, and suggest the single designation 
“Kaufman oculocerebrofacial syndrome”.
Introduction
Kaufman oculocerebrofacial syndrome (KOs; MIM 
244450) is an autosomal recessive disorder character-
ized by developmental delay and intellectual disability 
(ID), microcephaly, hypotonia, structural eye anoma-
lies and other organ malformations, as well as distinctive 
facial dysmorphic features. Fewer than 10 affected indi-
viduals had been reported from the first description in 
1971 to 2012 (Kaufman et al. 1971; Figuera et al. 1993; 
Garcia-Cruz et al. 1988; Dentici et al. 2011) when we 
redescribed the syndrome (under the acronym BPID syn-
drome, blepharophimosis–ptosis–intellectual disability 
syndrome; MIM 615057) and identified biallelic UBE3B 
mutations as the underlying cause (Basel-vanagaite et al. 
2012). In that report, patients with BPID syndrome were 
thought to have a distinctive condition because they lacked 
the eye abnormalities characteristic to patients with KOs, 
such as microphthalmia and optic nerve anomalies. there 
is a phenotypic overlap between KOs, toriello–Carey syn-
drome (tCs; agenesis of the corpus callosum with facial 
anomalies and Pierre-robin sequence; MIM 217980; tori-
ello et al. 2003) and the phenotype reported by Buntinx 
and Majewski as a “new” syndrome in 1990 (Buntinx and 
Majewski 1990). the differential diagnosis of KOs and 
related syndromes extends to other blepharophimosis–
intellectual disability syndromes (or Ohdo-like syndromes) 
such as Ohdo syndrome (MIM 249620), KAT6B-associated 
say-Barber/Biesecker/Young-simpson syndrome (MIM 
603736; Clayton-smith et al. 2011), MED12-associated 
Maat-Kievit-Brunner syndrome (MIM 300895; vulto-van 
silfhout et al. 2013), and Dubowitz syndrome (MIM 
223370) (reviewed by verloes et al. 2006).
Only six patients with KOs/BPID syndrome and bial-
lelic UBE3B mutations have been described previously 
(Basel-vanagaite et al. 2012; Flex et al. 2013). Here, we 
describe six additional patients and review the clinical and 
molecular spectrum of this recognizable entity.
Methods
Patient ascertainment and clinical evaluations
the study was approved by the ethics Committees of the 
Universities of Ulm and erlangen-nürnberg, and written 
informed consent was obtained from the patients’ parents 
or legal guardian. We report on six individuals from five 
unrelated families. the affected individuals were evaluated 
by routine medical history interviews and a physical exami-
nation, and clinical records were reviewed. all six patients 
had undergone brain imaging [magnetic resonance imaging 
(MrI) in patients 1-5 and computed tomography in patient 
6], and the MrI scans were reviewed by one radiologist 
(n.B.). a basic endocrinological evaluation had been per-
formed in all affected individuals.
In patients 1–3, KOs was not regarded as a differential 
diagnosis and mutations were identified following clinical 
diagnostic or research exome sequencing. after the reports 
on UBE3B mutations as the cause of KOs (Basel-vanagaite 
et al. 2012; Flex et al. 2013) the attending geneticists of 
patients 1–3 contacted l.B.-v. and G.B. UBE3B mutations 
were suspected in patients 4–6 based mainly on facial dys-
morphic features following a literature review performed 
by one of the authors (l.B.-v.) although these three chil-
dren had previously received clinical diagnoses different 
from KOs/BPID. Patients 4 and 5 are siblings and have 
been reported with a diagnosis of typical tCs (toriello 
et al. 2003); and patient 6 was reported by Buntinx and 
Majewski (1990).
exome and sanger sequencing
UBE3B mutations were identified by whole exome 
sequencing in patients 1–3 and by sanger sequencing of 
the coding exons and exon–intron boundaries in patients 
4–6. after the identification of a mutation in a sibling pair 
with a previous diagnosis of tCs, we sequenced UBE3B in 
four additional unrelated patients with tCs, two of whom 
have been reported previously (toriello et al. 2003). exome 
sequencing was performed using the sureselect Human 
all exon 50 Mb Kit (agilent) and a paired-end proto-
col on an Illumina Hiseq 2000 sequencer (patients 1 and 
3) or a sOliD 5500xl instrument (patient 2). reads were 
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aligned to the human genome assembly hg19 (GrCh37) 
and variants were called and annotated using software inte-
grated in the respective in-house exome analysis pipeline 
as described previously [Gandomi et al. 2013, for patients 
1 and 3; Hansen et al. 2013 (patient Mr043), for patient 
2]. this resulted in a mean coverage of 136, 97, and 92× 
in patients 1–3, respectively; and 91, 80, and 89 % of the 
target bases were covered 10× or more. In individuals born 
to consanguineous parents, we additionally performed a 
search for large regions of homozygosity, either by iden-
tifying runs of consecutive homozygous snPs in exome 
sequencing data essentially as described previously (Basel-
vanagaite et al. 2012) or by genotyping patient Dna with 
affymetrix Genome-wide Human snP 6.0 arrays. PCr 
and sanger sequencing were performed for the validation 
of variants of interest and for cosegregation studies.
In patients 4–6, the 26 UBE3B coding exons and respec-
tive exon–intron boundaries were sequenced on genomic 
Dna as described previously (Basel-vanagaite et al. 2012). 
Potentially disease-causing variants were analyzed for 
their frequency by querying the nHlBI exome sequenc-
ing Project database (exome variant server; http://evs.gs.
washington.edu/evs). In case of patient 2, we addition-
ally sequenced the UBE3B exons of interest in 188 turk-
ish control individuals. Polyphen-2 (http://genetics.bwh.
harvard.edu/pph2/index.shtml) and sIFt (http://sift.jcvi.org) 
were used to predict the impact of missense alterations on 
protein function.
Results
Clinical reports and identification of UBE3B mutations
Facial features of patients 1–6 are shown in Fig. 1, clini-
cal details are summarized in table 1, and brain MrIs are 
shown in supplementary Fig. 1.
Patient 1 (Fig. 1, picture 1; table 1) is a 33-year-old man 
with profound ID and no speech. He is the second son (of 
three) born to unaffected parents of Hispanic ancestry who 
are second cousins once removed. He presented at birth 
with muscular hypotonia and hearing impairment. Unlike 
the other patients in whom microcephaly or an occipito-
frontal circumference (OFC) <10th centile was observed, 
his OFC was at the 75th percentile. relative macrocephaly 
was probably of familial origin as his father was reported to 
be macrocephalic. Brain MrI showed moderately dilated 
lateral ventricles in patient 1 (supplementary Fig. 1) and 
diffuse anomalies of the white matter frontally. He has an 
abnormal sleep pattern and occasional violent behavior.
Using clinical diagnostic whole-exome sequencing, 
we detected a homozygous nonsense mutation in UBE3B, 
c.61G>t (p.Glu21*) (table 2; supplementary Fig. 2). the 
patient’s mother and unaffected brother were heterozygous 
carriers of the mutation, as shown by sanger sequencing; 
no Dna from the deceased father was available for genetic 
studies. In addition, alterations in two other ID-related 
genes were identified by exome sequencing and confirmed 
by sanger sequencing; namely, a rare homozygous mis-
sense alteration affecting a highly conserved amino acid, 
c.878G>a (p.arg293Gln; rs35267264), in KIAA1033, and 
a heterozygous missense alteration of a highly conserved 
amino acid, c.1307C>t (p.Pro436leu), in EHMT1. a sin-
gle homozygous KIAA1033 mutation has previously been 
suggested as the cause of moderate to severe ID, poor lan-
guage and adaptive skills, delayed fine motor development, 
and short stature in a family from Oman (ropers et al. 
2011). Heterozygous alterations in EHMT1 cause Kleefstra 
syndrome, which is characterized by severe ID, hypotonia, 
brachycephaly, flat face with hypertelorism, upslanting pal-
pebral fissures and a thick everted lower lip (Kleefstra et al. 
2006). the following evidence supports the homozygous 
UBE3B nonsense mutation, rather than one of the variants 
in KIAA1033 or EHMT1, as the major contributor to the 
Fig. 1  Facial features of the individuals described in this study. the numbers correspond to the numbers in table 1. ages of the patients are as 
follows: 1, 33 years; 2A, 8 months; 2B, 5 years 6 months; 3A, 4 months; 3B, 2 years; 4, 16 years; 5, 10 years 8 months; 6, 25 years
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patient’s phenotype: (1) His clinical presentation and facial 
dysmorphism are similar to those observed in other patients 
with KOs. (2) the KIAA1033 variant has a minor allele fre-
quency of 0.14 % (nHlBI exome variant server), suggest-
ing that it may be a rare polymorphism. notably, KIAA1033 
is located on chromosome 12q23.3, approximately 4.5 Mb 
away from UBE3B, and both genes are within a 46.6 Mb 
region of homozygosity on chromosome 12 in patient 
1, as determined by homozygosity analysis in the exome 
sequence. (3) Patient 1 has no facial features suggestive of 
Kleefstra syndrome. thus, although more than one of the 
three variants may contribute to the phenotype, including to 
clinical presentations that are atypical for KOs, the truncat-
ing UBE3B mutation is likely the major causative allele.
Patient 2 is a 7-year 5-month-old boy who presented 
with muscular hypotonia, congenital microcephaly and 
variable other anomalies (Fig. 1, pictures 2a and 2B; 
table 1). He developed minimal speech (5–10 single words 
at 7 years of age) and has an estimated IQ of 20–49. His 
unaffected parents are first cousins originating from tur-
key. Craniofacial dysmorphisms are mild, and he is the 
only patient in this study without blepharophimosis.
Whole-exome sequencing revealed two homozygous 
UBE3B missense mutations, c.1445t>a (p.leu482His) and 
c.1616t>C (p.leu539Pro; table 2, supplementary Fig. 2), 
with both parents being heterozygous for both mutations. 
UBE3B is located in a 21.75 Mb region of homozygosity in 
this patient’s exome. Both mutations affect conserved amino 
acid residues located outside the IQ and HeCt domains 
(Gong et al. 2003). therefore, the relatively mild craniofa-
cial phenotype in this patient might be related to the atypi-
cal location of the mutations compared to other patients, in 
whom missense alterations within the HeCt domain are 
predicted to have severe consequences. In silico analysis 
revealed that leu482 is located in a leucine-rich region span-
ning residues 472–500. the regular spacing of hydropho-
bic residues (every 7th amino acid position) resembles that 
of a leucine zipper (Hirst et al. 1996). such leucine zippers 
form dimers, suggesting that this UBe3B region might be 
involved in intermolecular interactions. a similar function 
can be assigned to the region around leu539, which is pre-
dicted to exhibit a coiled-coil structure (residues 512–560). 
For both mutation sites, the type of amino acid exchange will 
drastically affect the biophysical properties and is therefore 
likely to disrupt the respective protein-interaction motif.
Five other rare homozygous coding variants were con-
firmed by sanger sequencing (none affecting a known dis-
ease-associated gene; data not shown).
Patient 3 (Fig. 1, pictures 3a and 3B; table 1) is a 
24-month-old girl. she has congenital microcephaly (cur-
rently her OFC is at −4 sD), bilateral large complex preau-
ricular tags and stenotic external ear canals associated with 
moderate-to-severe conductive hearing impairment. she 
has significant feeding problems with gastroesophageal 
reflux and vomiting, requiring the placement of a gastros-
tomy tube (G-tube). she had two patches of hair on each 
cheek and hypertrichosis of the back. MrI scan showed 
partial agenesis of the corpus callosum and a frontal mid-
line mass, thought to be a lipoma (supplementary Fig. 1).
Clinical diagnostic whole exome sequencing 
revealed a homozygous missense mutation, c.2990G>C 
(p.arg997Pro), in UBE3B (table 2), affecting the HeCt 
domain. the mutation was confirmed by sanger sequenc-
ing (supplementary Fig. 2), and the parents were heterozy-
gous carriers of the mutation.
Patients 4 and 5 are siblings of Hispanic american origin 
with a clinical diagnosis of tCs (Fig. 3 and Fig. 2, respec-
tively, in toriello et al. 2003; table 1). recent pictures show-
ing their facial dysmorphic features are displayed in Fig. 1, 
pictures 4 and 5. the presence of UBE3B mutations was 
suspected after reviewing relevant scientific publications and 
noticing suggestive facial features (toriello et al. 2003).
Patient 4 is the older sibling and is currently 16 years 
old. From birth he has had severe respiratory and feeding 
problems with abnormal swallowing, which necessitated a 
nissen fundoplication with G-tube placement at 2 months. 
at age 16, he is still G-tube dependent. He required a tra-
cheostomy because of laryngomalacia and subglottic steno-
sis and underwent laryngotracheal reconstruction at 2 years 
6 months of age. at the age of 13 years, he was found to 
have scoliosis and focal progressive kyphosis requiring sur-
gical intervention.
Patient 5 is the 11-year-old younger sister of patient 4. 
she had a similar clinical presentation to that of her brother, 
including poor suck and severe respiratory problems. she 
also needed a tracheostomy because of tracheomalacia and 
is still tracheostomy dependent at age 11. she had signifi-
cant aspiration and obstructive sleep apnea. she also under-
went nissen fundoplication and was fed through a G-tube. 
In addition, she underwent bilateral tarsometatarsal release 
and left cuboid closing wedge osteotomy. Both sibs showed 
general hypertrichosis in their first year of life.
although their parents were not aware of consanguinity, 
snP-array genotyping detected two large (>10 Mb) blocks 
of homozygosity in each of the siblings, possibly indicat-
ing remote parental consanguinity. the single region of 
shared homozygosity was a 11.4 Mb segment on chromo-
some 12q23.3–q24.22 that contained UBE3B. sequencing 
of UBE3B revealed a homozygous c.2335G>a missense 
alteration in both affected sibs (p.Gly779arg; table 2, sup-
plementary Fig. 2); the parents were heterozygous carriers 
of the mutation. Gly779 is a highly conserved amino acid 
of the HeCt domain.
We next sequenced UBE3B in four additional patients 
with tCs, none of whom had the characteristic facial appear-
ance associated with KOs. We did not detect any mutations.
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Patient 6. this man (Fig. 1, picture 6; table 1) is cur-
rently 25 years old and the presence of a UBE3B mutation 
was suspected because of the recognition of characteristic 
facial features from a previously published report (Buntinx 
and Majewski 1990). the neonatal period was complicated 
by poor suck and hypotonia. Postaxial polydactyly of both 
hands was noticed at birth and treated by surgery. Cur-
rently, he has about 100 words and can speak in 3–4 word 
sentences.
sequencing of UBE3B revealed a compound heterozy-
gous mutation with a c.2098C>t (p.Gln700*) nonsense 
mutation inherited from his mother and a c.2990G>C 
(p.arg997Pro) mutation (table 2, supplementary Fig. 2), 
which was also present in his unaffected brother and likely 
inherited from their deceased father.
review of the clinical and laboratory features of patients 
with biallelic UBE3B mutations
table 1 summarizes clinical findings on the patients with 
biallelic UBE3B mutations reported here and previously 
(Basel-vanagaite et al. 2012; Flex et al. 2013).
Demographic data
Of the 12 patients with UBE3B mutations, seven were 
female. Consanguinity was reported in five of the families. 
In two families, there were two affected sibs.
Pregnancy and birth
no abnormal findings were reported following prenatal 
ultrasound except for polyhydramnion in one case and oli-
gohydramnion in one case. all the patients for whom data 
were available were born at term.
Growth
Birth weight was normal in most of the patients. the 
majority of patients had an OFC below the 10th centile at 
birth. Most affected children had failure to thrive and post-
natally decreasing age-matched OFC centiles. all but three 
affected individuals had short stature, and all but one had 
microcephaly or an OFC below the 10th centile.
Ectodermal abnormalities
sparse scalp hair was described in infancy in 6/12 patients. 
the appearance of the scalp hair improved with age. the 
skin was described as thin in six patients. three affected 
individuals had hypertrichosis, and two had eczema.
Craniofacial abnormalities
several patients were described as having a flat occiput 
or brachycephaly. Characteristic craniofacial features 
included arched, sparse and laterally flared eyebrows, 
Table 2  UBE3B mutations
Patient Origin Parental con-
sanguinity
Mutation 
(Dna)
Predicted effect 
on protein
Protein domain Control alleles
(evs)
Polyphen-2 sIFt
1 Hispanic 
american
second cousins 
once removed
c.61G>t 
homozygous
p.(Glu21*) truncation 
n-terminal to 
IQ and HeCt 
domains
0/13,006 n.a. n.a.
2 turkish First cousins c.1445t>a
homozygous
p.(leu482His) leucine-rich 
region
0/13,006
0/376 turk-
ish control 
alleles
Probably 
damaging
not tolerated
c.1616t>C
homozygous
p.(leu539Pro) Predicted 
coiled-coil 
domain
0/13,006
0/376 turk-
ish control 
alleles
Probably 
damaging
not tolerated
3 German and 
Irish
no c.2990G>C
homozygous
p.(arg997Pro) HeCt domain 0/13,006 Probably 
damaging
not tolerated
4 and 5 Mexican no c.2335G>a
homozygous
p.(Gly779arg) HeCt domain 0/13,006 Probably 
damaging
not tolerated
6 German no c.2098C>t
heterozygous
p.(Gln700*) truncation 
n-terminal 
to HeCt 
domain
0/13,006 n.a. n.a.
c.2990G>C
heterozygous
p.(arg997Pro) HeCt domain 0/13,006 Probably 
damaging
not tolerated
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blepharophimosis with epicanthal folds with or without 
ptosis, flat zygomata, a characteristic nasal shape with a 
relatively narrow nasal bridge and broad nasal base, a flat 
philtrum (long or short), and thin lips, especially the upper 
lip, with absent cupid’s bow, as well as a small mouth. the 
ears were often apparently low-set with over-folded helices 
or cupping, small earlobes and, in some instances, underde-
veloped ear crus. three patients had preauricular tags and 
two had stenotic external ear canals. With advancing age, 
the shape of the face became more elongated, the palpebral 
fissures became up-slanting and, in some patients the lip 
vermilion became more everted. One adult had a long chin 
and very thick alae nasi with narrow nares.
Respiratory tract abnormalities
six patients had breathing problems including tracheoma-
lacia, subglottic stenosis, laryngomalacia or stridor. two 
children needed a tracheostomy. two patients had a history 
of apnea either shortly after birth or obstructive sleep apnea 
later in life.
Cardiovascular system
Congenital heart malformations are not a common find-
ing in the UBE3B-related syndrome (3/12 patients). Heart 
defects included pulmonary artery stenosis, asD, vsD, 
and aortic coarctation.
Gastrointestinal tract abnormalities
eleven patients had feeding difficulties including poor suck 
and gastroesophageal reflux. three patients required G-tube 
feeding. Constipation was present in five individuals.
Urogenital abnormalities
Genital abnormalities were more frequent in females 
(although the difference is not statistically significant in 
this small series) and included hypoplastic labia majora 
and/or minora or clitoromegaly (4/6 females). Micropenis 
was described in 1/5 males. renal abnormalities included 
vesicoureteral reflux up to grade v and duplicated renal 
pelvis.
Skeletal abnormalities
skeletal abnormalities were observed in 10/12 individu-
als and included abnormal chest shape (bell-shaped tho-
rax, pectus carinatum) and long and slender fingers and 
toes. Clinodactyly of the fifth finger and hypoplastic distal 
phalanges were also reported. Congenital dysplasia of the 
hip was diagnosed in two newborns. Uncommon skeletal 
findings included polydactyly, coxa valga, scoliosis, con-
genital arthrogryposis, and metatarsus adductus.
Ocular abnormalities
three of the 12 patients had microcornea or microphthal-
mia, 6/12 strabismus, three coloboma of the iris, five myo-
pia with or without astigmatism, one hyperopia, three a 
pale optic disc, and two entropion.
Hearing loss
eight patients had hearing impairment, mostly conductive, 
but three individuals had sensorineural or mixed conduc-
tive–sensorineural hearing loss; and two had cholesteatoma.
Neurological abnormalities
Hypotonia and delayed motor milestones were observed 
in all affected individuals. six patients had seizures, often 
fever related. Independent walking was mostly achieved 
by 4–5 years of age; the gait was frequently described as 
unsteady. ID was present in all patients and was described 
as severe to profound. Only two patients developed speech, 
which in both cases was limited. structural Cns abnormal-
ities included absent or hypoplastic corpus callosum in six 
patients and a Chiari 1 malformation in two (supplemen-
tary Fig. 1).
Endocrine and cholesterol abnormalities
elevated tsH and reduced thyroid gland volume were 
diagnosed in one and low GH and aCtH in another patient. 
seven individuals had low cholesterol levels including low 
total cholesterol, low HDl, low lDl levels, or combina-
tions thereof.
Discussion
recognition of KOs should be possible on clinical grounds 
in many cases. a consistent and recognizable pattern of 
typical craniofacial features combined with hypotonia, fail-
ure to thrive, eye abnormalities, other congenital malforma-
tions, low cholesterol levels and severe ID should indeed 
facilitate early diagnosis of patients with UBE3B muta-
tions. We note, however, that neither ocular nor cerebral 
malformations are mandatory findings in this “oculocer-
ebrofacial” syndrome. evaluation of individuals with KOs 
should involve all body systems including assessment of 
the respiratory and gastrointestinal tracts, cardiologic and 
ophthalmologic evaluation, hearing tests, renal ultrasound, 
investigation of thyroid function and cholesterol levels, 
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developmental assessment and orthopedic evaluation. this 
series also illustrates the facial dysmorphism in adults with 
KOs and underscores the phenotypic variability, e.g., with 
respect to speech or limb involvement. although mild limb 
abnormalities such as long and slender fingers, clinodactyly 
and camptodactyly have been described in patients with 
UBE3B mutations, polydactyly has not been reported pre-
viously. While polydactyly may be a coincidental finding, 
a patient with facial features reminiscent of UBE3B-related 
features and polydactyly has been described by Gabrielli 
et al. (1994) as having a new form of oro-facio-digital syn-
drome. Other cases with suggestive clinical features—but 
no UBE3B sequence analysis yet—have been reported, 
such as the patient described by al Frayh and Haque 
(1987).
It is of interest that three patients, two described in this 
series and one in our previous study (patient 4 in Basel-
vanagaite et al. 2012, who is listed as patient 10 in our 
table 1), were diagnosed as having tCs. although patients 
with UBE3B mutations and patients originally described 
by toriello and Carey (1988) share several overlapping 
clinical features (short palpebral fissures, small nose with 
anteverted nares, abnormal ears, laryngeal anomalies, car-
diac defects, agenesis of the corpus callosum, microceph-
aly, micrognathia and cleft palate), the facial gestalt still 
is not completely similar. We note that the facial dysmor-
phic features of children with UBE3B mutations previously 
thought to have tCs are more similar to KOs than to the 
disorder originally described by toriello and Carey (1988). 
thus, UBE3B mutations define KOs which includes BPID 
syndrome, the phenotype described by Buntinx and Majew-
ski and a subset of patients previously diagnosed with tCs. 
Because Kaufman first described the typical clinical picture 
in 1971, we suggest—to avoid confusion—designating the 
syndrome with biallelic UBE3B mutations as “Kaufman 
oculocerebrofacial syndrome”.
apart from providing data expanding the clinical 
phenotype of KOs, our report illustrates some of the 
challenges and opportunities of exome sequencing in a 
clinical context. In patient 1, clinical exome sequencing 
detected rare variants in three ID-related genes. Whereas 
the clinical similarities with KOs highlighted the UBE3B 
mutation as the most relevant variant, we cannot exclude 
a contribution of the variants in KIAA1033 and EHMT1 
to the phenotype. large-scale studies have highlighted 
the difficulties in assigning a single variant to a patient’s 
phenotype, and in rare instances exome sequencing might 
even confirm two genetic diseases in one individual (Yang 
et al. 2013), and such situations probably make it difficult 
in some cases to assign a diagnosis on clinical grounds 
only. Furthermore, our data also illustrate how exome 
sequencing can help to establish a diagnosis in patients 
with a mild or atypical disease presentation and thereby 
contribute to the delineation of the phenotypic spectrum 
of rare genetic disorders. In patients 2 and 3, respectively, 
the mild and atypical facial dysmorphism had not raised 
the suspicion of a UBE3B-related disorder, but exome 
sequencing revealed a presumably causative homozygous 
missense variant in each case. the identification of mis-
sense alterations outside the HeCt domain in patient 2 
who presented with mild craniofacial dysmorphism with 
no blepharophimosis suggests a possible genotype–phe-
notype correlation. Future studies will establish whether 
missense changes outside the HeCt domain generally 
lead to a milder phenotype.
In conclusion, we report on six individuals with bial-
lelic UBE3B mutations, thereby doubling the number of 
reported patients. Identification of UBE3B mutations has 
merged phenotypes that were previously suspected to rep-
resent distinct syndromes into a single, possibly underdiag-
nosed disorder which can be clinically recognized.
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